I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 16% ± 1% | |
| plasmacytoid dendritic cell | 6 studies | 25% ± 6% | |
| natural killer cell | 5 studies | 18% ± 2% | |
| endothelial cell | 4 studies | 19% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
| non-classical monocyte | 3 studies | 22% ± 4% | |
| epithelial cell | 3 studies | 30% ± 4% | |
| ciliated cell | 3 studies | 21% ± 0% | |
| macrophage | 3 studies | 21% ± 2% | |
| GABAergic neuron | 3 studies | 18% ± 1% | |
| glutamatergic neuron | 3 studies | 24% ± 2% | |
| dendritic cell | 3 studies | 29% ± 8% |
